ApoGlyx
PrivateLast Round
VC Round
Oct 25, 2021
Total Funding Raised
$605,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
ApoGlyx operates in Healthcare & Life Sciences and is based in Lund. Its latest recorded funding round was a VC Round in October 2021.
ApoGlyx is a biotechnology company developing first-in-class therapies based on aquaporin inhibitors for inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ApoGlyx Comparables
Compare ApoGlyx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Arrivo BioVentures | 80% | |
| Lamassu BioTech | 78% | |
| CalciMedica Inc. | 73% |
For institutional investors. Book with your work email.
ApoGlyx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Oct 25, 2021 | ||||
| Seed | Jun 2, 2016 |
For institutional investors. Book with your work email.
ApoGlyx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LU Innovation | Seed |
| Almi Invest AB | VC Round |
| SmiLe Venture Hub | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 34% MoM, reaching 1.3K.
- May 18, 2026
Monthly visitors grew 48% MoM, reaching 1K.
For institutional investors. Book with your work email.
ApoGlyx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ApoGlyx's valuation, stock price, and market status.
Is ApoGlyx a public or private company?
ApoGlyx is a private company.
What is the current stock price of ApoGlyx?
ApoGlyx is a private company, so its shares have no public market price. Caplight tracks ApoGlyx's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ApoGlyx worth (valuation)?
Valuation information for ApoGlyx is not publicly available.
Can I buy ApoGlyx stock?
ApoGlyx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ApoGlyx's last funding round?
ApoGlyx's most recent funding round was VC Round on October 25, 2021.
Who are the main investors in ApoGlyx?
Key investors in ApoGlyx include Almi Invest AB.
Will ApoGlyx IPO soon?
No public IPO plans have been announced for ApoGlyx.
How can I track ApoGlyx secondary market activity?
Caplight tracks bids, offers, and trades in ApoGlyx's shares on secondary markets.